Physician profile
Diego S Illanes
NPI 1568529121
$276,941.05
in general payments reported to CMS, 2019-2025
34 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,225 · 2020: $26K · 2021: $30K · 2022: $21K · 2023: $76K · 2024: $58K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Consulting Fee: $78K · Travel and Lodging: $21K · Food and Beverage: $13K · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,935.00 |
| Consulting Fee | $78,431.91 |
| Travel and Lodging | $21,415.10 |
| Food and Beverage | $13,095.50 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $127,298.75 | 2019-2025 | Altis, Saffron |
| Medtronic, INC. | $65,587.60 | 2021-2025 | Interstim, Truclear, Ligasure |
| Astellas Pharma US INC | $36,062.74 | 2019-2025 | Veozah, Myrbetriq |
| Covidien Lp | $21,717.98 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $7,509.19 | 2025 | |
| Axonics, INC. | $5,283.45 | 2021-2024 | Bulkamid, Axonics |
| Dilon Technologies, INC. | $3,067.08 | 2023-2025 | Hemoblast Bellows |
| Gyrus Acmi, INC. | $2,500.00 | 2025 | Soltive |
| Davol INC. | $2,000.00 | 2021 | |
| Linvatec Corporation | $1,200.00 | 2020 | |
| Intuitive Surgical, INC. | $992.50 | 2019 | |
| Bolder Surgical, LLC | $675.00 | 2023 | Coolseal Generator |
| Boston Scientific Corporation | $560.46 | 2019-2025 | Axonics, Solyx Sis System, Capio Rp |
| Hologic Sales and Service, LLC | $500.00 | 2019 | |
| Medtronic USA, INC. | $392.39 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $292.91 | 2019-2023 | Harmonic |
| Caldera Medical, INC | $225.09 | 2021-2022 | |
| Karl Storz Endoscopy-America | $185.79 | 2023 | |
| Abbvie INC. | $161.05 | 2023-2025 | |
| Allergan, INC. | $103.89 | 2019-2021 | |
| Kci USA, INC. | $74.76 | 2020 | |
| Laborie Medical Technologies Corp. | $69.23 | 2022-2023 | |
| Urovant Sciences INC | $68.95 | 2021-2022 | |
| Pfizer INC. | $59.91 | 2020-2022 | |
| Dentsply Ih INC. | $54.98 | 2021-2022 | |
| Conmed Corporation | $47.76 | 2020 | |
| Acera Surgical, INC. | $47.74 | 2025 | Restrata Wound Matrix |
| Convatec INC. | $46.15 | 2023 | |
| Therapeuticsmd, INC. | $39.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $34.81 | 2023 | Keytruda, Lynparza |
| 180 Medical, INC. | $26.80 | 2025 | Gentlecath |
| Sumitomo Pharma America, INC. | $24.87 | 2024 | Gemtesa |
| Rochester Medical Corporation | $16.25 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.88 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Illanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.